why choose us

First received: December 07, 2022

Clinical Trial: Prenatal Aspirin and Postpartum Vascular Function

Study Status: Completed

Recruit Status: RECRUITING

Condition: Preeclampsia

Study Type: INTERVENTIONAL


Official Title: Protective Mechanisms of Prenatal Aspirin Therapy on Maternal Vascular Dysfunction Following Preeclampsia

Brief Summary: Preeclampsia is a pregnancy disorder affecting ~5-10% of pregnancies in the United States.Women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life, even if they are otherwise healthy.The reason why this occurs is unclear but may be related to blood vessel damage and increased inflammation that occurs during the preeclamptic pregnancy and persists postpartum.Low dose aspirin (LDA; 75-150mg/daily) is currently the most effective and clinically…

Read more